Vivozon Pharmaceutical announced on the 22nd that it has applied for product approval from the Ministry of Food and Drug Safety for the non-narcotic analgesic 'Onapraju (Ophiranzerin Hydrochloride)'.
The indication is 'moderate to severe acute pain, including postoperative pain.' The contract manufacturing organization for the entire process is the US company Jubilant HollisterStier, LLC.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
